# Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Final rule; correction.
**SUMMARY:**
The Food and Drug Administration (FDA, the Agency, or we) is correcting a final rule that published in the *Federal Register* of July 29, 2020. That final rule requires electronic submission of certain postmarketing safety reports for approved new animal drugs and provides a procedure for requesting a temporary waiver of the electronic submission requirement. Table 2 of the final rule published with errors and this document corrects those errors. We are placing a corrected copy of the final rule in the docket.
**DATES:**
Effective September 22, 2020.
**FOR FURTHER INFORMATION CONTACT:**
Linda Walter-Grimm, Center for Veterinary Medicine (HFV-240), Food and Drug Administration, 7519 Standish Pl., MPN4, Rm. 2666, Rockville, MD 20855, 240-402-5762, *[email protected]* .
**SUPPLEMENTARY INFORMATION:**
In the *Federal Register* of July 29, 2020, (85 FR 45505), FDA published the final rule “Postmarketing Safety Reports for Approved New Animal Drugs; Electronic Submission Requirements” with errors in table 2.
In FR Doc. 2020-15441, appearing on page 45509 in the *Federal Register* of July 29, 2020, the following corrections are made:
| | Primary | Lower bound | Upper bound | Primary | Lower bound | Upper bound |
| --- | --- | --- | --- | --- | --- | --- |
| Present Value of Costs | $69,720 | | | $75,346 | | |
| Present Value of Cost Savings | 73,557 | | | 171,634 | | |
| Present Value of Net Costs | (3,837) | | | (96,287) | | |
| Annualized Costs | 4,880 | | | 2,260 | | |
| Annualized Cost Savings | 5,149 | | | 5,149 | | |
| Annualized Net Costs | (269) | | | (2,889) | | |
Dated: August 14, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.